Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:4031671.
doi: 10.1155/2017/4031671. Epub 2017 Oct 25.

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon- γ Release Assay-Positive Patients

Affiliations

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon- γ Release Assay-Positive Patients

Changguo Chen et al. Dis Markers. 2017.

Abstract

Tuberculosis is caused by mycobacterium, a potentially fatal infectious bacterium. In recent years, TB cases increased in the whole world. WHO statistics data shows that the world's annual tuberculosis incidence was 8~10 million with about 3 million deaths. Several studies have shown that susceptibility to tuberculosis may be associated with IFNGR1 gene polymorphisms. Here, we report the distribution frequency of IFNGR1 gene polymorphisms in 103 cases of IGA-negative patients and 100 cases of IGA-positive patients from China by sequencing the IFNGR1 proximal ~750 bp promoter region. We found a total of 5 types of site mutations: -611 (G/A), -56 (T/C), -255 (C/T), -359 (T/C), and -72 (C/T). The two main types of gene polymorphisms among the IGA-negative and IGA-positive groups were -611 (G/A), with mutation rates of 88.3% and 78.4%, respectively, and -56 (T/C), with mutation rates of 84.5% and 83.8%, respectively, which had no statistical significance, and there was no correlation with the incidence of tuberculosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Similar articles

Cited by

  • Interferons: Tug of War Between Bacteria and Their Host.
    Alphonse N, Dickenson RE, Odendall C. Alphonse N, et al. Front Cell Infect Microbiol. 2021 Mar 10;11:624094. doi: 10.3389/fcimb.2021.624094. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33777837 Free PMC article. Review.

References

    1. Lin P. L., Flynn J. L. Understanding latent tuberculosis: a moving target. The Journal of Immunology. 2010;185(1):15–22. doi: 10.4049/jimmunol.0903856. - DOI - PMC - PubMed
    1. Kondratieva T., Azhikina T., Nikonenko B., Kaprelyants A., Apt A. Latent tuberculosis infection: what we know about its genetic control? Tuberculosis. 2014;94(5):462–468. doi: 10.1016/j.tube.2014.06.009. - DOI - PubMed
    1. Raviglione M., Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infectious Disease Reports. 2016;8(2):p. 6570. doi: 10.4081/idr.2016.6570. - DOI - PMC - PubMed
    1. Mjid M., Cherif J., Ben Salah N., et al. Epidemiology of tuberculosis. Revue de Pneumologie Clinique. 2015;71(2-3):67–72. doi: 10.1016/j.pneumo.2014.04.002. - DOI - PubMed
    1. Zumla A., George A., Sharma V., Herbert N., Baroness Masham of Ilton WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities. The Lancet. 2013;382(9907):1765–1767. doi: 10.1016/S0140-6736(13)62078-4. - DOI - PubMed

Substances